SALM1 controls synapse development by promoting F-actin/PIP2-dependent Neurexin clustering.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
02 09 2019
Historique:
received: 03 12 2018
revised: 20 06 2019
accepted: 25 06 2019
pubmed: 2 8 2019
medline: 24 12 2019
entrez: 2 8 2019
Statut: ppublish

Résumé

Synapse development requires spatiotemporally regulated recruitment of synaptic proteins. In this study, we describe a novel presynaptic mechanism of cis-regulated oligomerization of adhesion molecules that controls synaptogenesis. We identified synaptic adhesion-like molecule 1 (SALM1) as a constituent of the proposed presynaptic Munc18/CASK/Mint1/Lin7b organizer complex. SALM1 preferentially localized to presynaptic compartments of excitatory hippocampal neurons. SALM1 depletion in excitatory hippocampal primary neurons impaired Neurexin1β- and Neuroligin1-mediated excitatory synaptogenesis and reduced synaptic vesicle clustering, synaptic transmission, and synaptic vesicle release. SALM1 promoted Neurexin1β clustering in an F-actin- and PIP2-dependent manner. Two basic residues in SALM1's juxtamembrane polybasic domain are essential for this clustering. Together, these data show that SALM1 is a presynaptic organizer of synapse development by promoting F-actin/PIP2-dependent clustering of Neurexin.

Identifiants

pubmed: 31368584
doi: 10.15252/embj.2018101289
pmc: PMC6717895
doi:

Substances chimiques

Actins 0
Calcium-Binding Proteins 0
Cell Adhesion Molecules, Neuronal 0
Lrfn2 protein, mouse 0
Membrane Glycoproteins 0
Nerve Tissue Proteins 0
Neural Cell Adhesion Molecules 0
Nrxn1 protein, mouse 0
Phosphatidylinositol 4,5-Diphosphate 0
neuroligin 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e101289

Subventions

Organisme : European Research Council
ID : 322966
Pays : International
Organisme : ZonMw (Netherlands Organisation for Health Research and Development)
ID : 91111009
Pays : International

Informations de copyright

© 2019 The Authors. Published under the terms of the CC BY 4.0 license.

Références

Science. 2002 Aug 30;297(5586):1525-31
pubmed: 12202822
Neuron. 2009 Dec 24;64(6):799-806
pubmed: 20064388
J Neurosci. 2005 Mar 9;25(10):2557-65
pubmed: 15758165
Nature. 2011 Oct 23;479(7374):552-5
pubmed: 22020284
Curr Opin Cell Biol. 2007 Oct;19(5):543-50
pubmed: 17935964
Mol Psychiatry. 2017 Mar;22(3):375-383
pubmed: 27217145
J Neurosci. 2010 Apr 21;30(16):5559-68
pubmed: 20410109
Nat Commun. 2017 Jun 12;8:15800
pubmed: 28604739
J Biol Chem. 2012 Feb 10;287(7):4470-84
pubmed: 22174418
J Neurosci. 1996 Apr 15;16(8):2488-94
pubmed: 8786425
Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22699-704
pubmed: 21149722
Mol Cell. 2005 Jan 21;17(2):181-91
pubmed: 15664188
Trends Cell Biol. 2006 Aug;16(8):413-20
pubmed: 16839766
Physiol Rev. 2010 Jan;90(1):259-89
pubmed: 20086078
Nat Rev Neurosci. 2007 Mar;8(3):206-20
pubmed: 17299456
Cell Rep. 2015 Sep 8;12(10):1618-30
pubmed: 26321637
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):E5222-31
pubmed: 27531958
J Biol Chem. 2008 Mar 28;283(13):8395-405
pubmed: 18227064
Front Mol Neurosci. 2018 Apr 05;11:105
pubmed: 29674953
Mol Cell Neurosci. 2005 Jul;29(3):436-52
pubmed: 15894489
Nat Commun. 2016 Aug 02;7:12328
pubmed: 27480238
J Neurosci. 2002 Jun 1;22(11):4264-73
pubmed: 12040031
Cell. 2017 Nov 2;171(4):745-769
pubmed: 29100073
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17998-8003
pubmed: 19822762
J Neurosci. 2007 Mar 14;27(11):2815-24
pubmed: 17360903
Neuron. 2006 Jul 20;51(2):171-8
pubmed: 16846852
Sci Rep. 2014 Sep 10;4:6056
pubmed: 25205456
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19432-7
pubmed: 23129658
Neuron. 2007 Jun 21;54(6):919-31
pubmed: 17582332
J Neurosci Methods. 2011 Feb 15;195(2):185-93
pubmed: 21167201
Cell. 1998 Sep 18;94(6):773-82
pubmed: 9753324
Nat Commun. 2018 Jan 18;9(1):268
pubmed: 29348579
Cell. 2004 Dec 29;119(7):1013-26
pubmed: 15620359
Neuron. 2015 Aug 19;87(4):781-96
pubmed: 26291161
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
Nat Rev Neurosci. 2016 Jan;17(1):22-35
pubmed: 26656254
Sci Rep. 2016 May 26;6:26676
pubmed: 27225731
Neuron. 2018 Jul 25;99(2):329-344.e7
pubmed: 29983322
Neuron. 2007 Apr 19;54(2):275-90
pubmed: 17442248
Neuron. 2010 Dec 9;68(5):894-906
pubmed: 21145003
Neuron. 2006 Apr 20;50(2):233-45
pubmed: 16630835
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4057-62
pubmed: 23345436
J Neurosci. 2006 Feb 22;26(8):2174-83
pubmed: 16495444
Neuron. 2006 Sep 21;51(6):773-86
pubmed: 16982422
Neuron. 2017 May 3;94(3):611-625.e4
pubmed: 28472659
EMBO J. 2019 Sep 2;38(17):e101289
pubmed: 31368584
Neuron. 2015 Jul 15;87(2):326-40
pubmed: 26182417
Nat Commun. 2018 Jan 18;9(1):269
pubmed: 29348429
Cell. 2000 Jun 9;101(6):657-69
pubmed: 10892652
Nat Neurosci. 2003 Jul;6(7):708-16
pubmed: 12796785
J Neurosci. 2018 Jun 27;38(26):5872-5887
pubmed: 29798891
Gene. 2006 Oct 1;380(2):72-83
pubmed: 16828986
Nat Protoc. 2007;2(3):670-6
pubmed: 17406629
EMBO J. 2011 Sep 16;30(23):4728-38
pubmed: 21926970
Science. 2005 Feb 25;307(5713):1324-8
pubmed: 15681343
J Neurosci Res. 1999 Dec 15;58(6):831-5
pubmed: 10583914
J Biol Chem. 2001 Dec 21;276(51):47869-76
pubmed: 11604393

Auteurs

Marinka Brouwer (M)

Department of Clinical Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

Fatima Farzana (F)

Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

Frank Koopmans (F)

Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

Ning Chen (N)

Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

Jessie W Brunner (JW)

Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

Silvia Oldani (S)

Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

Ka Wan Li (KW)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

Jan Rt van Weering (JR)

Department of Clinical Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

August B Smit (AB)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

Ruud F Toonen (RF)

Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

Matthijs Verhage (M)

Department of Clinical Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH